SABCS 2023: Pi3king the Right Target
Dr. Cynthia Ma, MD, PhD moderates a session reviewing Pi3kinase in breast cancer: 1. PI3K past, present, and future by Neil Vasan, MD,PhD 2. Identifying Collateral Vulnerabilities in the AKT pathway for Therapeutic Benefit with Alex Toker, PhD 3. The mTOR pathway with Robert J. Schneider, PhD
▶︎
Phase 2 Study of Multi-Cancer Detection from Breath Samples
▶︎
SABCS 2023: Toxicity Management - Next Gen Therapies Means Next Gen Toxicities
▶︎
JCO at ASCO 2026: Pemigatinib Phase 3 FIGHT-302 Trial in Cholangiocarcinoma
▶︎
Read The Korea Economic Daily in 30 Minutes | 20260511🌞#MorningRoutine
▶︎
JCO PO Article Insights: Longitudinal Monitoring of Anti-EGFR Based Therapy in CRC
▶︎
AI Is Creating A Rare Opportunity For Investors. How Jim Roppel Is Playing It. | Investing With IBD
▶︎
What is SonarQube | Introduction SonarQube | SonarQube Tutorial | SonarQube Basics | Intellipaat
▶︎
What's the deal with the Iran deal? | feat. Lt. Col. (Ret.) Jonathan Conricus & Behnam Ben Taleblu
▶︎
Why Purpose Is The Only Path To Fulfillment
▶︎
Read The Korea Economic Daily in 30 Minutes | 05/27/2026🌞#MorningRoutine
▶︎
Jfrog | Jfrog Artifactory | Jfrog Artifactory Tutorial | Artifactory Tutorial | Intellipaat
▶︎
RASolute-302 with Daraxonrasib - Game Changer at ASCO 2026 in Pancreatic Cancer
▶︎
Scalable Tools to Map T Cell Recognition | Dr Stephanie Gaglione (Gladstone Institutes & MIT)
▶︎
Putin ready for anything. Follow the live broadcast with Alessandro Orsini
▶︎
How to increase your vocabulary: Live English Class
▶︎
Trump sta per invadere l’Iran? La diretta con Alessandro Orsini
▶︎
SABCS 2024: Targeting the ER and PI3K pathway - novel drugs and combinations
▶︎
LRR Pediatrics for FMGE 2026 By Dr. Meenakshi Bothra
▶︎
LRR Microbiology for FMGE 2026 By Dr. Preeti Sharma
▶︎